F.i.t Group Joint Stock Company (FIT.VN) Stock

FIT.VN logo

F.i.t Group Joint Stock Company

FIT.VNVietnam
Healthcare

Company profile

F.i.t Group Joint Stock reported revenue of 2.07 trillion VND for fiscal year 2025, up 6.1% from fiscal year 2024, and net income of 39.98 billion VND. That is a net profit margin of 1.9% for fiscal year 2025. In Q1 2026 (the quarter ended March 31, 2026) revenue was 493.79 billion VND, down 4.2% from a year before. In Q1 2026 it reported a net loss of 4.41 billion VND, against net income of 16.19 billion VND a year earlier. Our analysis of its filings shows revenue growing from 1.75 trillion VND in fiscal year 2023 to 2.07 trillion VND in fiscal year 2025, 9.0% a year on average. F.i.t Group Joint Stock reports about 1,820 full-time employees.

What stands out

  • Net income fell 66.5% in fiscal year 2025, from 119.26 billion VND in fiscal year 2024.
  • Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.

Figures from company filings; latest fiscal year ended December 31, 2025.

About F.i.t Group Joint Stock Company

F.I.T Group Joint Stock Company engages in the manufacturing and trading of medicine and medical equipment in Vietnam. It operates through three segments: Consultancy and Investment, Agriculture, and Pharmaceuticals and Medical Equipment. The Consultancy and Investment segment offers services, including investment consultancy, M&A consultancy, equitization consultancy, corporate governance consultancy, market development consultancy, business financial management consultancy, human resource development consultancy, real estate brokerage, and leasing offices, as well as trading real estate and managing parking areas and public facilities. The Agriculture segment engages in the trading, processing, and exporting of agricultural products, plant varieties, seeds, consumer goods, mineral water, and related services. The Pharmaceuticals and Medical Equipment segment focuses on trading pharmaceuticals, medical equipment, producing capsules, and manufacturing medical devices. The company also conducts financial investment activities, including investments in shares of unlisted companies, capital contributions, and investment cooperation contracts. In addition, the company invests in stocks and bonds, as well as in businesses operating in large-scale sectors; and offers investment consulting services comprising consulting on corporate restructuring, corporate financial management, and business valuation. Further, it manufactures and exports canned and frozen vegetables; produces mineral water, green tea, and tonics; and offers cosmetics. The company was formerly known as F.I.T Investment Joint Stock Company and changed its name to F.I.T Group Joint Stock Company in October 2016. F.I.T Group Joint Stock Company was founded in 2007 and is based in Hanoi, Vietnam.

Leadership

  • Sang Van Nguyen — Founder & Chairman of the Board, 50
  • Cao The Do — Chief Financial Officer
  • Cuong Viet Le — Chief Accountant, 33
  • Hoai Thi Minh Vu — General Director, Member of Management Board & Director, 37
  • Nguyet Thi Minh Nguyen — Founder & Vice Chairman, 55

How much revenue does F.i.t Group Joint Stock make?

F.i.t Group Joint Stock reported 2.07 trillion VND in revenue for fiscal year 2025, up 6.1% from 1.95 trillion VND in fiscal year 2024. In Q1 2026 revenue was 493.79 billion VND.

What companies are similar to F.i.t Group Joint Stock?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include DHG Pharmaceutical Joint Stock Company (DHG.VN), Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (DBD.VN), Cuu Long Pharmaceutical Joint Stock Company (DCL.VN).

Has F.i.t Group Joint Stock made a profit in recent years?

Net income by fiscal year: FY2021, 157.97 billion VND; FY2022, 48.29 billion VND; FY2023, a loss of 135.50 billion VND; FY2024, 119.26 billion VND; FY2025, 39.98 billion VND. It reported a net loss in 1 of these 5 years.

How has F.i.t Group Joint Stock's revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, 1.22 trillion VND; FY2022, 1.92 trillion VND; FY2023, 1.75 trillion VND; FY2024, 1.95 trillion VND; FY2025, 2.07 trillion VND.

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
Employees1,820
FoundedMar 8, 2007
IPO DateAug 7, 2015
IPO StatusPublic
HeadquartersHanoi, Vietnam
ExchangeHOSE
TimezoneAsia/Bangkok (ICT)

Contact & Links

Address
Times Tower, HACC1 Complex, Hanoi
Phone
84 24 730 94688
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “F.i.t Group Joint Stock Company (FIT.VN)”, data as of Mar 31, 2026, https://dataporium.tech/stocks/FIT.VN

LinkedInLinkedInXXYouTubeYouTube